SCHEMBL7011147

SCHEMBL7011147

O=C1CCN(Cc2cc(Cc3csc4ccccc34)cc3ccccc23)C(=O)CN1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CRHBP P24387 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ FAAH O00519 1/20 0.34
▸ DRD2 P14416 5/20 0.33
▸ DRD4 P21917 5/20 0.33
▸ DRD3 P35462 5/20 0.33
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ CYP2A6 P11509 2/20 0.32
▸ FFAR2 O15552 3/20 0.32
▸ DDB1 Q16531 1/20 0.31
▸ CRBN Q96SW2 1/20 0.31
▸ CMA1 P23946 1/20 0.31
▸ HTR1A P08908 1/20 0.30
▸ F10 P00742 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094297 0.82 BCHE (0.42) SMN1; SMN2DRD2DRD4DRD3
SCHEMBL5234914 0.80 CYP2C9 (0.41) SMN1; SMN2DRD4DDB1CRBN
SCHEMBL5230507 0.67 MAPT (0.43) CHRNA7SMN1; SMN2CRHBPCRHR2DRD2
SCHEMBL7007730 0.66 CCR2 (0.36) —
SCHEMBL15596049 0.63 CHRNA7 (0.51) CHRNA7SMN1; SMN2CRHBPCRHR2FAAH
SCHEMBL7068604 0.61 CYP2A6 (0.62) CHRNA7SMN1; SMN2CRHBPCRHR2CYP2A6
SCHEMBL24939864 0.59 CHRNA7 (0.49) CHRNA7SMN1; SMN2CRHBPCRHR2FAAH
SCHEMBL10210828 0.59 CHRNA7 (0.97) CHRNA7SMN1; SMN2CRHBPCRHR2FAAH
SCHEMBL807363 0.58 CHRNA7 (1.00) CHRNA7SMN1; SMN2CRHBPCRHR2FAAH
SCHEMBL877544 0.58 KMT2A (0.57) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296961-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-02 — — EP disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 — — WO disclosed
Send feedback